Extension of Time to File SOU

AMAZE

LEO Pharma A/S

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88821077
LAW OFFICE ASSIGNED LAW OFFICE 115
MARK SECTION
MARK AMAZE (see, http://uspto.report/TM/88821077/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT AMAZE
OWNER SECTION (current)
NAME LEO Pharma A/S
MAILING ADDRESS Industriparken 55
CITY Ballerup
ZIP/POSTAL CODE 2750
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Denmark
EMAIL XXXX
OWNER SECTION (proposed)
NAME LEO Pharma A/S
MAILING ADDRESS Industriparken 55
CITY Ballerup
ZIP/POSTAL CODE 2750
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Denmark
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME B. Brett Heavner
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing@finnegan.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) b.brett.heavner@finnegan.com; Jennifer.Coles@finnegan.comm
DOCKET/REFERENCE NUMBER 14894.53
CORRESPONDENCE INFORMATION (proposed)
NAME B. Brett Heavner
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing@finnegan.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) b.brett.heavner@finnegan.com; Jennifer.Coles@finnegan.comm
DOCKET/REFERENCE NUMBER 14894.53
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and for treatment of the skin
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 038
CURRENT IDENTIFICATION Providing online forums for users for the sharing and transmission of information and messages about skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Scientific and medical research in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; Pharmaceutical and scientific research and development services, scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific and pharmaceutical research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 044
CURRENT IDENTIFICATION Medical services in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical and pharmaceutical consultation services and health consultation services, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 11/10/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 4
SUBTOTAL AMOUNT [EXTENSION FEE] 500
TOTAL AMOUNT 500
SIGNATURE SECTION
SIGNATURE /B. Brett Heavner/
SIGNATORY'S NAME B. Brett Heavner
SIGNATORY'S POSITION Attorney of Record
DATE SIGNED 05/06/2021
SIGNATORY'S PHONE NUMBER 202-408-4000
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Thu May 06 11:45:06 ET 2021
TEAS STAMP USPTO/ESU-XX.XXX.X.X-2021
0506114506516787-88821077
-780a824aafb7bb328e50cb1d
a4cf68fe9bc4bf13468990a90
25b78dc0118f35d4-CC-45030
326-20210506103208460127



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: AMAZE (see, http://uspto.report/TM/88821077/mark.png)
SERIAL NUMBER: 88821077

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: LEO Pharma A/S, having an address of
      Industriparken 55
      Ballerup, 2750
      Denmark
      Email: XXXX
Proposed: LEO Pharma A/S, having an address of
      Industriparken 55
      Ballerup, 2750
      Denmark
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 11/10/2020.

For International Class 005:
Current identification: Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and for treatment of the skin

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 038:
Current identification: Providing online forums for users for the sharing and transmission of information and messages about skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Scientific and medical research in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; Pharmaceutical and scientific research and development services, scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific and pharmaceutical research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 044:
Current identification: Medical services in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical and pharmaceutical consultation services and health consultation services, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      B. Brett Heavner
      PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): b.brett.heavner@finnegan.com; Jennifer.Coles@finnegan.comm

Correspondence Information (proposed):
      B. Brett Heavner
      PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): b.brett.heavner@finnegan.com; Jennifer.Coles@finnegan.comm


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $500 will be submitted with the form, representing payment for 4 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /B. Brett Heavner/      Date Signed: 05/06/2021
Signatory's Name: B. Brett Heavner
Signatory's Position: Attorney of Record
Signatory's Phone: 202-408-4000
Signature method: Sent to third party for signature

PAYMENT: 88821077
PAYMENT DATE: 05/06/2021

Serial Number: 88821077
Internet Transmission Date: Thu May 06 11:45:06 ET 2021
TEAS Stamp: USPTO/ESU-XX.XXX.X.X-2021050611450651678
7-88821077-780a824aafb7bb328e50cb1da4cf6
8fe9bc4bf13468990a9025b78dc0118f35d4-CC-
45030326-20210506103208460127




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed